Loading clinical trials...
Loading clinical trials...
Between 2013-2014, our study network of U.S. emergency departments, EMERGEncy ID NET, found that the rate of fluoroquinolone-resistant E. coli was 11.7% among all patients, 6.3% in uncomplicated and 1...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Olive View-UCLA Education & Research Institute
Collaborators
NCT07655050 · Kidney Calculi, Urolithiasis, and more
NCT05711446 · Urinary Tract Infections, Kidney Transplant; Complications
NCT04791579 · Neurogenic Bladder, Post-operative Urinary Tract Infections
NCT06976125 · Urinary Tract Infections
NCT05488340 · Urinary Tract Infections
Olive View-UCLA Medical Center
Sylmar, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions